SCHEMBL7323246

SCHEMBL7323246

CCc1ccccc1C1(O[C@H](C)[C@H](N)C(=O)O)c2ccccc2-c2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 4/20 0.38
CYP2D6 P10635 2/20 0.38
SLC1A3 P43003 3/20 0.37
SLC1A2 P43004 3/20 0.37
SLC1A1 P43005 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C19 P33261 2/20 0.37
MEN1 O00255 1/20 0.37
CYP2C9 P11712 1/20 0.37
KMT2A Q03164 1/20 0.37
PPARG P37231 1/20 0.35
PPARA Q07869 1/20 0.35
S1PR4 O95977 2/20 0.35
HDAC4 P56524 1/20 0.35
PDK2 Q15119 2/20 0.34
HIF1A Q16665 1/20 0.34
APEX1 P27695 1/20 0.33
THRB P10828 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7323239 1.00 KIF11 (0.38) KIF11CYP2D6SLC1A3SLC1A2SLC1A1
SCHEMBL7325812 0.84 KIF11 (0.38) KIF11CYP2D6SLC1A3SLC1A2SLC1A1
SCHEMBL7325808 0.84 KIF11 (0.38) KIF11CYP2D6SLC1A3SLC1A2SLC1A1
SCHEMBL7323931 0.84 KIF11 (0.40) KIF11CYP2D6SLC1A3SLC1A2SLC1A1
SCHEMBL7323926 0.84 KIF11 (0.40) KIF11CYP2D6SLC1A3SLC1A2SLC1A1
SCHEMBL7323867 0.84 KIF11 (0.44) KIF11CYP2D6SLC1A3SLC1A2SLC1A1
SCHEMBL7317362 0.84 KIF11 (0.44) KIF11CYP2D6SLC1A3SLC1A2SLC1A1
SCHEMBL7317367 0.84 KIF11 (0.44) KIF11CYP2D6SLC1A3SLC1A2SLC1A1
SCHEMBL7312197 0.83 SLC1A3 (0.35) KIF11CYP2D6SLC1A3SLC1A2SLC1A1
SCHEMBL7312191 0.83 SLC1A3 (0.35) KIF11CYP2D6SLC1A3SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6162824-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS ALLELIX NEUROSCIENCE INC. 2000-12-19 US disclosed